Learning Objectives:
- Review the mechanism of action of 5-fluorouracil, and
become familiar with the cytotoxic metabolites that
cause early-onset toxicity.
- Understand the causes of 5-fluorouracil overdose, and
the “red flags” of unusual, early-onset severe toxicity.
- Describe how uridine triacetate provides an emergency
treatment for adult and pediatric patients following a
fluorouracil or capecitabine overdose and who exhibit
early-onset, severe or life threatening toxicity.
- Provide information on the administration of uridine
triacetate oral granules and its limitations of use.
This Non-CNE Symposium is co-sponsored by BTG International Inc. and Wellstat Therapeutics.
Symposia events require separate registration. Please click here to register for this event.
